| 论文标题： | |
|---|---|
| 作者： | |
| 出版刊物： | |
| 出版日期： | |
| 出版年份： | |
| 卷/期： | |
| DOI： | |
| 论文摘要： | Metformin is the world's widely prescribed oral medication for the treatment of type 2 diabetes mellitus, which is also shown to repress tumorigenesis without a complete understanding of its therapeutic targets. Here, it is shown that metformin impairs the growth of breast cancer cells by inhibiting PRMT6, a protein arginine methyltransferase primarily responsible for asymmetric dimethylation of histone H3 arginine 2 (H3R2me2a). Mechanistically, metformin directly binds PRMT6 and inhibits its activity to methylate H3R2, leading to PRMT6 transcriptional repression and further reduces H3R2me2a. By decreasing PRMT6-catalyzed H3R2me2a, metformin enhances the chromatin association of UHRF1, an accessory factor of DNMT1 to promote DNA methylation and repress the transcription of DNA replication-associated genes, resulting in retarded DNA replication and cell cycle arrest. Metformin and a DNA replication inhibitor synergistically inhibit tumor growth. Furthermore, genetic disruption of the interaction between metformin and PRMT6 attenuates the inhibitory effect of metformin on breast cancer growth. Together, this work identifies a previously unrecognized mechanism for metformin to inhibit breast cancer growth. |
以下内容与「星空体育彩票携手欧联杯开启官方合作」同属公开资讯，可按栏目接着查阅相关条目。
本站按公开材料组织页面。需要原文时请核对应栏目发布页。
若从搜索引擎进入，可先确认当前栏目名称，再按需打开相关阅读。
